Opinions in Healthcare

Kisunla: A New Breakthrough for Alzheimer’s Disease The FDA’s approval of Kisunla (donanemab-azbt) marks a significant advancement in the treatment of early-stage Alzheimer’s disease. Kisunla was developed by Eli Lilly, and this new